Oncorus, Inc.·4

Oct 5, 7:10 PM ET

Goldberg John Mayer 4

4 · Oncorus, Inc. · Filed Oct 5, 2020

Insider Transaction Report

Form 4
Period: 2020-10-01
Goldberg John Mayer
SVP, Clinical Development
Transactions
  • Award

    Employee Stock Option (right to buy)

    2020-10-01+56,28556,285 total
    Exercise: $15.00Exp: 2030-09-14Common Stock (56,285 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on September 15, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION